Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/29/2010WO2010132670A3 Pentacycline compounds
12/29/2010WO2010127246A3 Hnf4 modulators and methods of use
12/29/2010WO2010106509A3 Hcv-derived polypeptides and uses thereof
12/29/2010WO2010088222A3 A high molecular weight polysaccharide that binds and inhibits virus
12/29/2010WO2010063996A3 Antibacterial compounds
12/29/2010WO2009141835A3 Formulations, herbal medicated threads and preparing processes thereof
12/29/2010EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein
12/29/2010EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject
12/29/2010EP2267132A2 Polyepitopic protein fragments of HPV proteins E6 and E7, method for obtaining same and uses thereof, in particular for vaccination
12/29/2010EP2267122A1 Controlled dissolution crosslinked protein crystals
12/29/2010EP2267120A1 Recombinant vaccinia virus having hepatitis c virus gene
12/29/2010EP2267113A1 Culture medium for Neisseria meningitidis with soy bean extract as amino acid source and no protein complexes of animal origin
12/29/2010EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267027A2 Method of administering therapeutic polypeptides, and polypeptides therefor
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267004A2 Peptide derived from hepatitis C virus
12/29/2010EP2266995A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
12/29/2010EP2266971A2 Hiv protease inhibiting compounds
12/29/2010EP2266958A1 Antiviral agent
12/29/2010EP2266956A2 Pleuromutilin derivatives useful as antibacterials
12/29/2010EP2266955A1 Mutilin derivatives and their use as pharmaceutical
12/29/2010EP2266947A1 Ester derivatives as competitive inhibitors of type II dehydroquinase enzyme
12/29/2010EP2266665A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/29/2010EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/29/2010EP2266607A2 Immunoconjugates for treating cancer
12/29/2010EP2266606A1 Methods and compositions for the prevention and treatment of sepsis
12/29/2010EP2266605A1 Vaccines comprising aluminium adjuvants and histidine
12/29/2010EP2266604A2 Adjuvant systems and vaccines
12/29/2010EP2266595A2 Treatment of infections and other disorders
12/29/2010EP2266579A1 Pharmaceutical composition comprising elvucitavine
12/29/2010EP2266553A1 Butenafine hydrochloride-containing aqueous patch
12/29/2010EP2266535A2 Controlled release compositions for interferon based on block polymers
12/29/2010EP2265639A1 Compositions comprising antibodies or antibody fragments
12/29/2010EP2265626A2 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
12/29/2010EP2265606A1 Hepatitis c virus inhibitors
12/29/2010EP2265584A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity
12/29/2010EP2265267A1 Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
12/29/2010EP2265117A1 Inhibitors of protein phosphatase-1 and uses thereof
12/29/2010EP2084175B1 Hcv nucleoside inhibitor
12/29/2010EP2044085B1 Penem prodrugs
12/29/2010EP1933823B1 Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium
12/29/2010EP1857453B1 Fluoroalkylpyrrolidine derivatives
12/29/2010EP1748789B1 IL-22 for preventing infectious diseases
12/29/2010EP1660134B1 Conjugates of hydroxyalkyl starch and g-csf
12/29/2010EP1560827B1 Anti-infective agents
12/29/2010EP1545429B1 Compositions containing citric acid for the treatment of nail fungal infections
12/29/2010EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
12/29/2010EP1504095B2 Site specific listeria integration vectors and methods for using the same
12/29/2010EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta
12/29/2010EP1425305B1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
12/29/2010EP1372603B1 Topical application for treating toenail fungus
12/29/2010EP1107722B1 A method for the treatment of staphylococcal infection
12/29/2010EP1077678B1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
12/29/2010CN201684602U Cefprozi reaction kettle
12/29/2010CN1995345B Recombinant L-251 protein with anti-inflammatory effect secreted by Japanese lamprey oral gland
12/29/2010CN1976723B Use of preparing medicine for treating or preventing infectious diseases
12/29/2010CN1956707B Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-D-glutamic acid (LK-423)
12/29/2010CN1935262B Use of red Nocardia cyto skeleton for preparing anti human papillomavirus medicine
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN1899361B Zhenqi medicinal composition and its preparation
12/29/2010CN1799550B Highly efficient formulation of hepsera and preparation method thereof
12/29/2010CN1739519B Itraconazole emulsion for injection and its preparation
12/29/2010CN101932590A 2',4'-substituted nucleosides as antiviral agents
12/29/2010CN101932579A New imidazolo-heteroaryl derivatives with antibacterial properties
12/29/2010CN101932328A Antiviral agents, antiviral fibers and antiviral fiber structures
12/29/2010CN101932325A Ido inhibitors
12/29/2010CN101932322A Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid
12/29/2010CN101932320A Membrane fusion inhibitor
12/29/2010CN101932318A Composition for stimulating natural killer cell activity
12/29/2010CN101928728A Method for preparing enterovirus virus-like particle and application thereof
12/29/2010CN101928351A Sulphonated Gleditia sinensis Lam polysaccharide and application thereof
12/29/2010CN101928343A Monoclonal antibodies to the CLFA protein and method of use in treating or preventing infections
12/29/2010CN101928340A Group of antibacterial peptide derivatives and application thereof
12/29/2010CN101928331A New compound and application thereof
12/29/2010CN101928330A New compound and application thereof
12/29/2010CN101928295A Antibiotics containing borinic acid complexes and methods of use
12/29/2010CN101928284A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/29/2010CN101928283A Compound with anti-HCV activity and application thereof
12/29/2010CN101928262A Biologically active methylene blue derivatives
12/29/2010CN101928253A 2-[5-(2-hydroxyphenyl]-4H-1,2,4-triazole-3-thioether]-1-acetophenone compound or pharmaceutically acceptable salt and preparation and application thereof
12/29/2010CN101928246A N-[(1-aryl-3-substituted phenyl-pyrazol-4-yl) methenyl]-2-hydroxyl benzoyl hydrazine compound or pharmaceutically acceptable salts and preparation method thereof
12/29/2010CN101928228A Amantadine derivative with anti-influenza virus activity and preparation method thereof
12/29/2010CN101927004A Macromolecule slow controlled release long-acting sterilizing product and preparation method thereof
12/29/2010CN101927000A Medicine composite of superfine sterile sodium carbonate and cephems
12/29/2010CN101926999A Hemostatic disinfectant and preparation method thereof
12/29/2010CN101926995A Asparagus immunologic adjuvant and influenza vaccines containing same
12/29/2010CN101926994A Turtle shell immunoadjuvant and influenza vaccine containing the same
12/29/2010CN101926993A Adjuvant systems and vaccines
12/29/2010CN101926992A Recombined attenuated live vaccine for preventing and treating I-type or II-type infection of herpes simplex virus and preparation method thereof
12/29/2010CN101926991A Classical swine fever virus vaccine and production method thereof
12/29/2010CN101926990A Swelling cell virus vsocs gene-deleted attenuated live vaccine and preparation method and application thereof
12/29/2010CN101926989A Recombinant attenuated Salmonella typhimurium vector vaccine for expressing JEV (Japanese Encephalitis Virus) immunogenic gene as well as preparation method thereof
12/29/2010CN101926988A Injectable vaccines against multiple meningococcal serogroups
12/29/2010CN101926987A Method for producing piglet paratyphoid live vaccine by using synthetic medium
12/29/2010CN101926986A Vibriosis-resisting attenuated live vaccine and preparation method and application thereof
12/29/2010CN101926975A Method for extracting medicine for killing hepatitis C virus from ginger
12/29/2010CN101926968A Traditional Chinese medicine for treating acquired immune deficiency syndrome
12/29/2010CN101926948A Uigur medicament for treating AIDS and preparation method thereof
12/29/2010CN101926928A Method for extracting medicament for killing hepatitis C virus from garlic
12/29/2010CN101926925A Natural mineral haemorrhoids and eczema ointment
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 1798